Search Results - "Ten Bokkel Huinink, Sebastiaan"

Prognostic Value of the Modified Rutgeerts Score for Long-Term Outcomes After Primary Ileocecal Resection in Crohn's Disease by Bak, Michiel T J, Ten Bokkel Huinink, Sebastiaan, Erler, Nicole S, Bodelier, Alexander G L, Dijkstra, Gerard, Romberg-Camps, Mariëlle, de Boer, Nanne K H, Hoentjen, Frank, Stassen, Laurents P S, van der Meulen-de Jong, Andrea E, West, Rachel L, van Ruler, Oddeke, van der Woude, C Janneke, de Vries, Annemarie C

“…The prognostic value of the modified Rutgeerts score (mRS) in patients with Crohn's disease (CD) needs to be further elucidated. This study assessed the…”
Get full text

Re-induction with intravenous Ustekinumab after secondary loss of response is a valid optimization strategy in Crohn’s disease by ten Bokkel Huinink, Sebastiaan, Biemans, Vince, Duijvestein, Marjolijn, Pierik, Marieke, Hoentjen, Frank, West, Rachel L., van der Woude, Christien J., de Vries, Annemarie C.

“…Re-induction with intravenous ustekinumab after secondary loss of response in Crohn's disease is a relatively new strategy to regain efficacy. This real-world…”
Get full text

Retreatment with anti-tumor necrosis factor therapy in combination with an immunomodulator for recurrence of Crohn’s disease after ileocecal resection results in prolonged continuation as compared to anti-tumor necrosis factor monotherapy by ten Bokkel Huinink, Sebastiaan, Beelen, Evelien M.J., ten Bokkel Huinink, Thomas, Hoentjen, Frank, G. L. Bodelier, Alexander, Dijkstra, Gerard, Romberg-Camps, Marielle, de Boer, Nanne K., Stassen, Laurents P.S., van der Meulen, Andrea E., West, Rachel, van Ruler, Oddeke, van der Woude, C. Janneke, de Vries, Annemarie C.

“…Background A considerable proportion of Crohn’s disease patients that undergo ileocecal resection (ICR) have failed anti-tumor necrosis factor (TNF) therapy…”
Get full text

Low‐FODMAP Diet Is Associated With Improved Quality of Life in IBS Patients—A Prospective Observational Study by Kortlever, Tim L., Ten Bokkel Huinink, Sebastiaan, Offereins, Marleen, Hebblethwaite, Clarice, O'Brien, Leigh, Leeper, Julie, Mulder, Chris J. J., Barrett, Jacqueline S., Gearry, Richard B.

“…Background The low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol (FODMAP) diet is effectively manages irritable bowel syndrome (IBS)…”
Get full text

Discontinuation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn's Disease: Individual Participant Data Meta-Analysis of 309 Patients from 12 Studies by Ten Bokkel Huinink, Sebastiaan, Thomassen, Doranne, Steyerberg, Ewout W, Pauwels, Renske W M, Casanova, Maria J, Bouguen, Guillaume, Mak, Joyce W Y, Molnár, Tamas, Lobo, Alan J, Seidelin, Jacob B, Amiot, Aurelien, D'Haens, Geert, Rivière, Pauline, Guidi, Luisa, Bor, Renata, Lin, Wei-Chen, Peyrin-Biroulet, Laurent, Gisbert, Javier P, Janneke van der Woude, C, de Vries, Annemarie C

“…The risk of relapse after anti-tumour necrosis factor [TNF] therapy discontinuation in Crohn's disease patients with perianal fistulas [pCD] is unclear. We…”
Get full text

Observational Study of Perspectives of Inflammatory Bowel Disease Patients Concerning the Use of Corticosteroids by Asl Baakhtari, Sadaf, McCombie, Andrew, Ten Bokkel Huinink, Sebastiaan, Irving, Peter, Siegel, Corey A, Mulder, Roger, Mulder, Chris J, Gearry, Richard

“…We aimed to investigate the factors that make inflammatory bowel disease (IBD) patients more or less likely to be willing to take corticosteroids. Respondents…”
Get more information

Measuring Diet Intake and Gastrointestinal Symptoms in Irritable Bowel Syndrome: Validation of the Food and Symptom Times Diary by Wright-McNaughton, Morag, Ten Bokkel Huinink, Sebastiaan, Frampton, Christopher M A, McCombie, Andrew M, Talley, Nicholas J, Skidmore, Paula M L, Gearry, Richard B

“…Patients with irritable bowel syndrome (IBS) identify food as a trigger for the onset or worsening of gastrointestinal symptoms. Despite this, there is no…”
Get full text

Tu1818 POSTOPERATIVE PROPHYLAXIS PREVENTS SURGICAL AND SEVERE ENDOSCOPIC RECURRENCE AFTER PRIMARY ILEOCECAL RESECTION IN CROHN'S DISEASE by Huinink, Sebastiaan ten Bokkel, Bak, Michiel T., Beelen, Evelien, Erler, Nicole S., Hoentjen, Frank, Bodelier, Alexander, Dijkstra, Gerard, Romberg-Camps, Mariëlle, de Boer, Nanne, Stassen, Laurents P., De Jong, Andrea V. Meulen, West, Rachel, van Ruler, Oddeke, Van Der Woude, Christien Janneke, De Vries, Annemarie C.

Get full text

Re-induction with intravenous Ustekinumab after secondary loss of response is a valid optimization strategy in Crohn’s disease by ten Bokkel Huinink, Sebastiaan, Biemans, Vince, Duijvestein, Marjolijn, Pierik, Marieke, Hoentjen, Frank, West, Rachel L., van der Woude, Christien J., de Vries, Annemarie C.

Get full text

Early fecal calprotectin levels at week 8 may guide therapeutic decisions on Ustekinumab therapy in patients with Crohn's disease by Pauwels, Renske W. M., ten Bokkel Huinink, Sebastiaan, van der Woude, Christien J., Doukas, M., Oudijk, L., de Vries, Annemarie C.

“…Response evaluation after induction therapy with ustekinumab (UST) in Crohn's disease (CD) is important for decisions on maintenance therapy. We aimed to…”
Get full text

Sa1958 – Measuring Diet Intake and Gastrointestinal Symptoms in Irritable Bowel Syndrome: Validation of the Food and Symptom Times (FAST) Diary with Fodmap Analysis by Wright-McNaughton, Morag, Macintosh, Alice, Huinink, Sebastiaan Ten Bokkel, Frampton, Christopher, McCombie, Andrew, Dwyer, Erin G., Talley, Nicholas J., Muir, Jane, Roy, Nicole, Skidmore, Paula, Gearry, Richard B.

Get full text

Validation and update of a prediction model for risk of relapse after cessation of anti-TNF treatment in Crohn’s disease by ten Bokkel Huinink, Sebastiaan, de Jong, Djuna C., Nieboer, Daan, Thomassen, Doranne, Steyerberg, Ewout W., Dijkgraaf, Marcel G.W., Bodelier, Alexander G.L., West, Rachel L., Römkens, Tessa E.H., Hoentjen, Frank, Mallant, Rosalie C., van Tuyl, Bas A.C., Mares, Wout G.N., Wolfhagen, Frank H.J., Dijkstra, Gerard, Reijnders, Jurriën G.P., de Boer, Nanne K., Tan, Adriaan C.I.T.L., van Boeckel, Petra G.A., Tack, Greetje J., van Asseldonk, Dirk P., D’Haens, Geert R.A.M., van der Woude, C Janneke, Duijvestein, Marjolijn, de Vries, Annemarie C

“…Background Anti-tumor necrosis factor (TNF) therapy is effective for the treatment of Crohn’s disease. Cessation may be considered in patients with a low risk…”
Get full text